Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
17:38:34 EDT Tue 15 Jul 2025
Enter Symbol
or Name
USA
CA



Q:ARAY - ACCURAY INCORPORATED - https://www.accuray.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
ARAY - Q0.21.21·1.380.41.33-0.03-2.2624.17781,5421.39  1.39  1.3252.945  1.140116:40:35Jun 0615 min RT 2¢

Recent Trades - Last 10 of 1542
Time ETExPriceChangeVolume
16:40:35Q1.3203-0.039799
16:34:29Q1.33-0.03140
16:24:24Q1.33-0.032
16:04:11Q1.33-0.031
16:04:09Q1.33-0.031
16:04:09Q1.33-0.031
16:04:02Q1.33-0.031
16:02:10Q1.33-0.032,203
16:02:08Q1.33-0.03597
16:00:16Q1.33-0.031

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2025-06-06 07:30U:ARAYNews ReleaseAccuray Announces Convertible Notes Exchange and Refinancing of Existing Credit Facilities
2025-05-29 19:30U:ARAYNews ReleaseAccuray to Participate in the Jefferies Global Healthcare Conference 2025
2025-05-07 07:35U:ARAYNews ReleaseAccuray Showcases New Long-Term Data Superscript 1 on Benefits of 5 Session Radiotherapy Treatment for Men with Prostate Cancer at ESTRO 2025
2025-05-05 16:10U:ARAYNews ReleaseAccuray Announces First SRS/SBRT Patient Treatments in Austria With the CyberKnife(TM) System
2025-04-30 16:05U:ARAYNews ReleaseAccuray Reports Fiscal 2025 Third Quarter Financial Results
2025-04-16 16:05U:ARAYNews ReleaseAccuray to Report Third Quarter Fiscal 2025 Financial Results on April 30, 2025
2025-04-03 07:35U:ARAYNews ReleaseAccuray CyberKnife(TM) Platform Featured in New Studies Showcasing its Benefits in Central Nervous System Tumors Presented at Radiosurgery Society Scientific Meeting
2025-03-12 07:30U:ARAYNews ReleaseAccuray to Participate at 37th Annual Roth Conference
2025-02-05 16:05U:ARAYNews ReleaseAccuray Reports Strong Fiscal 2025 Second Quarter Financial Results & Raises Guidance
2025-01-23 07:35U:ARAYNews ReleaseAccuray Announces First 100 Patient Treatment Regimens Completed in China Using the Tomo(TM) C Radiation Treatment Delivery System, a CNNC-Accuray Joint Venture Product
2025-01-22 16:05U:ARAYNews ReleaseAccuray to Report Second Quarter Fiscal 2025 Financial Results on February 5, 2025
2025-01-21 09:15U:ARAYNews ReleaseLeonel Peralta to Join Accuray as Chief Operations Officer
2025-01-13 15:00U:ARAYNews ReleaseAccuray Announces China National Medical Products Administration Approval of the Radixact(TM) SynC(TM) and CyberKnife(TM) S7(TM) Systems; Expands on the China Product Portfolio that Includes the Recently Approved Tomo(TM) C System
2024-12-18 07:35U:ARAYNews ReleaseNew Data Indicates the CyberKnife(TM) System Can Provide a Safe and Effective Treatment Option to Control Brainstem Metastases, an Extremely Challenging Location to Treat
2024-11-26 16:03U:ARAYNews ReleaseAccuray Incorporated Reports Inducement Award Under NASDAQ Listing Rules
2024-11-06 16:05U:ARAYNews ReleaseAccuray Reports Fiscal 2025 First Quarter Financial Results
2024-10-23 16:05U:ARAYNews ReleaseAccuray to Report First Quarter Fiscal 2025 Financial Results on November 6, 2024
2024-10-21 16:05U:ARAYNews ReleaseAccuray Appoints Michael Murphy as VP, Corporate Controller
2024-10-17 07:00U:ARAYNews ReleaseNew England Journal of Medicine Study Reaffirms Five Session Radiation Treatment Provides Comparable Rates of Cancer Control, Tolerability and Sexual Functioning to Conventional Radiotherapy Treatment in Men with Localized Prostate Cancer
2024-10-15 08:45U:ARAYNews ReleaseAccuray President and Chief Executive Officer Suzanne Winter Returns from Medical Leave of Absence